Effects of MK-801 and amphetamine treatments on allergic lung inflammatory response in mice. 2013

Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
Neuroimmunomodulation Research Group, Department of Pathology, School of Veterinary Medicine, University of São Paulo, São Paulo, SP, Brazil.

Glutamate acts as a neurotransmitter within the Central Nervous System (CNS) and modifies immune cell activity. In lymphocytes, NMDA glutamate receptors regulate intracellular calcium, the production of reactive oxygen species and cytokine synthesis. MK-801, a NMDA receptor open-channel blocker, inhibits calcium entry into mast cells, thereby preventing mast cell degranulation. Several lines of evidence have shown the involvement of NMDA glutamate receptors in amphetamine (AMPH)-induced effects. AMPH treatment has been reported to modify allergic lung inflammation. This study evaluated the effects of MK-801 (0.25mg/kg) and AMPH (2.0mg/kg), given alone or in combination, on allergic lung inflammation in mice and the possible involvement of NMDA receptors in this process. In OVA-sensitized and challenged mice, AMPH and MK-801 given alone decreased cellular migration into the lung, reduced IL-13 and IL10 levels in BAL supernatant, reduced ICAM-1 and L-selectin expression in granulocytes in the BAL and decreased mast cell degranulation. AMPH treatment also decreased IL-5 levels. When both drugs were administered, treatment with MK-801 reversed the decrease in the number of eosinophils and neutrophils induced by AMPH in the BAL of OVA-sensitized and challenged mice as well as the effects on the expression of L-selectin and ICAM-1 in granulocytes, the IL-10, IL-5 and IL-13 levels in BAL supernatants and increased mast cell degranulation. At the same time, treatment with MK-801, AMPH or with MK-801+AMPH increased corticosterone serum levels in allergic mice. These results are discussed in light of possible indirect effects of AMPH and MK-801 via endocrine outflow from the CNS (i.e., HPA-axis activity) to the periphery and/or as a consequence of the direct action of these drugs on immune cell activity, with emphasis given to mast cell participation in the allergic lung response of mice.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010047 Ovalbumin An albumin obtained from the white of eggs. It is a member of the serpin superfamily. Serpin B14
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D012130 Respiratory Hypersensitivity A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL. Airway Hyperresponsiveness,Hypersensitivity, Respiratory,Airway Hyper-Responsiveness,Airway Hyper Responsiveness,Airway Hyperresponsivenesses,Hyper-Responsiveness, Airway,Hyperresponsiveness, Airway,Respiratory Hypersensitivities
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids

Related Publications

Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
April 2000, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
July 2011, Progress in neuro-psychopharmacology & biological psychiatry,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
April 2002, Progress in neuro-psychopharmacology & biological psychiatry,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
January 2003, Neuropsychobiology,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
January 1998, Pharmacology, biochemistry, and behavior,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
May 2019, Brain research,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
January 1992, Psychopharmacology,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
January 2013, Neurotoxicology and teratology,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
July 2002, Neuroscience letters,
Eduardo Kenji Hamasato, and Ana Paula Ligeiro de Oliveira, and Adriana Lino-dos-Santos-Franco, and Alison Ribeiro, and Viviane Ferraz de Paula, and Jean Pierre Schatzmann Peron, and Amílcar Sabino Damazo, and Wothan Tavares-de-Lima, and João Palermo-Neto
January 2004, Neuroimmunomodulation,
Copied contents to your clipboard!